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Abstract
Background: Mesenchymal stem cell (MSC) found in bone marrow (BM-MSCs) and the Wharton’s jelly matrix of
human umbilical cord (WJ-MSCs) are able to transdifferentiate into neuronal lineage cells both in vitro and in vivo
and therefore hold the potential to treat neural disorders such as stroke or Parkinson’s disease. In bone marrow
MSCs, miR-130a and miR-206 have been show to regulate the synthesis of neurotransmitter substance P in human
mesenchymal stem cell-derived neuronal cells. However, how neuronal differentiation is controlled in WJ-MSC
remains unclear.
Methods: WJ-MSCs were isolated from human umbilical cords. We subjected WJ-MSCs into neurogenesis by a
published protocol, and the miRNome patterns of WJ-MSCs and their neuronal progenitors (day 9 after
differentiation) were analyzed by the Agilent microRNA microarray.
Results: Five miRNAs were enriched in WJ-MSCs, including miR-345, miR-106a, miR-17-5p, miR-20a and miR-20b.
Another 11 miRNAs (miR-206, miR-34a, miR-374, miR-424, miR-100, miR-101, miR-323, miR-368, miR-137, miR-138
and miR-377) were abundantly expressed in transdifferentiated neuronal progenitors. Among these miRNAs, miR-
34a and miR-206 were the only 2 miRNAs been linked to BM-MSC neurogenesis. Overexpressing miR-34a in cells
suppressed the expression of 136 neuronal progenitor genes, which all possess putative miR-34a binding sites.
Gene enrichment analysis according to the Gene Ontology database showed that those 136 genes were
associated with cell motility, energy production (including those with oxidative phosphorylation, electron transport
and ATP synthesis) and actin cytoskeleton organization, indicating that miR-34a plays a critical role in precursor cell
migration. Knocking down endogenous miR-34a expression in WJ-MSCs resulted in the augment of WJ-MSC
motility.
Conclusions: Our data suggest a critical role of miRNAs in MSC neuronal differentiation, and miR-34a contributes
in neuronal precursor motility, which may be crucial for stem cells to home to the target sites they should be.
Background
Studies on implantation of human mesenchymal stem
cells (MSCs) to treat neural disorders such as stroke or
Parkinson’s disease and stroke have shown promised
potentials [1,2]. So far human bone marrow is the most
common MSC source, but yield of MSC from bone
marrow significantly decreases with donor age [3]. Many
researchers thereby have searched for alternative sources
of MSC in adult and extraembryonic tissues such as pla-
centa, amniotic membrane, and umbilical cord. The
Wharton’s jelly part, a matrix of mucous connective tis-
sue of umbilical cord surrounding and protecting umbi-
lical cord arteries and vein, is enriched with fibroblast-
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[4,5].
WJ-MSCs hold the potentials to transdifferentiate into
neuronal lineage cells both in vitro and in vivo [2,4,6,7].
Cells cultured in low serum medium supplemented with
basic fibroblast growth factor (bFGF) have been success-
fully induced to differentiate into glial cells and neurons
in vitro [4]. A three-step method (neural induction,
neural commitment and the neural differentiation step)
could successfully induce in vitro neural differentiation
of WJ-MSCs [2]. Fu and colleagues also successfully
transdifferentiated WJ-MSCs into neurons in vitro by
using neuronal conditioned medium (NCM) derived
from the culture supernatants of 7-day postnatal Spra-
gue-Dawley rat brains [6]. WJ-MSCs could further dif-
ferentiate into dopaminergic neurons for treating
Parkinsonian rats [8]. The in vivo neural differentiation
ability of WJ-MSCs was demonstrated later by Weiss et
al. that WJ-MSCs can transdifferentiate into cells of
neuronal lineage in vivo by transplantation of WJ-MSCs
in a hemiparkinsonian rat model [1]. In vivo neural dif-
ferentiation of WJ-MSCs was further confirmed after
intracerebral transplantation of WJ-MSCs in cerebral
ischemic rats [2] or after transplantation into spinal
cord transaction rats [9].
There have been studies focused on the neural differ-
entiation mechanisms of MSCs. Wang and colleagues
showed that the protein kinase A (PKA) signal trans-
duction pathway mediates the neural differentiation of
cord blood MSCs [10]. MicroRNAs (miRNAs) are a
class of 18- to 24-nt, small, noncoding RNAs, which
bind the 3’ UTR of target mRNAs to mediate transla-
tional repression in cells [11-13]. MiRNAs have been
shown to regulate cancer and developmental processes,
such as stem cell self-renewal, neuronal differentiation,
cell motility, and cell proliferation [14-20]. In bone
marrow MSCs, miR-130a and miR-206 have been show
to regulate the synthesis of neurotransmitter substance
P in human mesenchymal stem cell-derived neuronal
cells [21]. However, there is no study so far addressing
the impacts of miRNAs on neural differentiation of
WJ-MSC. Since MSCs from bone marrow and umbili-
cal cord are quite distinct in terms of differentiation
abilities and mRNA expression patterns [22], it is likely
that miRNAs involved in WJ-MSC neural transdiffer-
entiation are also distinct from those in BM-MSC
neurogenesis.
Here, we report the first miRNA profile of undifferen-
tiated human WJ-MSCs and WJ-MSC-derived neuronal
precursors using a published differentiation protocol for
BM-MSC [21]. MicroRNAs that were increased in the
neuronal cells and decreased during neural differentia-
tion were analyzed by bioinformatics algorithm to pre-
dict their mRNA targets and hence their function.
Methods
Isolation and cultivation of human MSCs
This research follows the tenets of the Declaration of
Helsinki and informed consent was obtained from the
donor patients. All human MSCs used for experiment
were cultured for less than 8 passages in the Mesen-
Cult™ medium (StemCell Technologies, Vancouver, BC,
Canada) in the presence of 5% CO2,o ri nD u l b e c c o ’s
modified Eagle’s medium (DMEM; Cat. 12100-061;
Gibco-BRL, Paisley, U.K) supplemented with 10% fetal
bovine serum (FBS; Cat. 12003; JRH Bioscience, KS,
USA). MSCs from Wharton’s jelly were collected as
published [22]. Briefly, umbilical cords (UCs) were pro-
cessed within 24 h after delivery. Wharton’s jelly tissues
were isolated from UCs and then digested with collage-
nase and trypsin. Cells were washed twice with PBS and
plated on regular culture dishes in fresh culture med-
ium, non-adherent cells were discarded on next day.
Approximately 4 days to 1 week after expansion, fibro-
blast-like adherent cells were detached using trypsin-
EDTA solution and then reseeded in fresh culture med-
ium without dilution for further expansion (Passage 1:
P1). Neural transdifferentiation was performed accord-
ing to a published protocol [21]. Immunofluorescence
assays (IFA) were carried as descried [23] using an anti-
NeuN mAb (1:100; Millipore, Billerica, MA).
MicroRNA microarray and data analysis
The Agilent Human miRNA Microarray Kit V2 (Agilent,
Foster City, CA, USA) containing probes for 723 human
microRNAs from the Sanger database v10.1 was used.
GeneSpring GX 9 software (Agilent, USA) was used for
value extraction. A 2-tailed Student’s t-test was then
used for the calculation of the p value for each miRNA
probe. Heat maps were created by the dChip software
http://www.dchip.org/. To predict the downstream
mRNA targets of the miRNAs, the TargetScan web tool
http://www.targetscan.org/ was used.
Gene expression microarray probe preparation and data
analysis
Total RNA collection, cRNA probe preparation, array
hybridization and data analysis were done as previously
described [24]. In brief, Affymetrix™ HG-U133 Plus 2.0
whole genome array was used. RMA log expression
units were calculated from Affymetrix GeneChip array
data using the ‘affy’ package of the Bioconductor http://
www.bioconductor.org/ suite of software for the R sta-
tistical programming language http://www.r-project.org/.
The default RMA settings were used to background cor-
rect, normalize and summarize all expression values.
Significant difference between sample groups was identi-
fied using the method described by Storey & Tibshirani
[24]. Briefly, a t-statistic was calculated as normal for
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fied permutation test [24]. To control the multiple test-
ing errors, a false discovery rate (FDR) algorithm was
then applied to these p-values to calculate a set of q-
values: thresholds of the expected proportion of false
positives, or false rejections of the null hypothesis. Gene
annotation was performed by the ArrayFusion web tool
http://microarray.ym.edu.tw/tools/arrayfusion/[25]. Gene
enrichment analysis was performed by the Gene Ontol-
o g y( G O )d a t a b a s eu s i n gt h eW e b G e s t a l th t t p : / / b i o i n f o .
vanderbilt.edu/webgestalt/ interface and the DAVID
Bioinformatics Resources 6.7 database http://david.abcc.
ncifcrf.gov/ by a hypergeometric test.
RNA isolation and real-time quantitative polymerase
chain reaction (qPCR)
Total RNA were extracted by Trizol (Invitrogen, Carls-
bad, CA, USA) and 100 ng to 1 μg of total RNA were
performed reverse transcription using the SuperScript™
III Reverse transcriptase kit (Invitrogen) as directed by
the manufacturer. The expression of matured human
miRNAs was determined by a stem-loop real-time PCR
system
27. The PCR reverse primer for miRNA was
GTGCAGGGTCCGAGGT. The miRNA expression data
were normalized to that of U6 snRNA, which was
amplified with the specific forward and reverse primers
5’-CTCGCTTCGGCAGCAC-3’ and 5’-AACGCTTCAC-
GAATTTGCG-3’, respectively. Real-time PCR reactions
were performed using Maxima™ SYBR Green qPCR
Master Mix (Cat. K0222; Fermentas, Glen Burnie, Mary-
land, USA), and specific products were detected and
analyzed using a StepOne™ sequence detector (Applied
Biosystems, USA).
Transwell cell migration assay
Cell migration ability was evaluated using Costar Trans-
well
® Polycarbonate Permeable Supports (Corning, NY,
USA). Briefly, 5 × 10
4 cells in 400 μl of culture medium
were applied to the upper chamber of the device, and
600 μl of medium was added to the lower chamber. A
polycarbonate membrane with a pore size of 8 μmw a s
placed in between the two chambers. After 6 hours of
incubation at 37°C, the membrane was fixed in 4% par-
aformaldehyde (Sigma-Aldrich) for 20 minutes at room
temperature and then stained with Hoechst 33342 solu-
tion (Sigma-Aldrich) for 30 minutes. Migrated cells on
the membrane were counted under a microscope.
Results
The miRNA signature associated with WJ-MSC neuronal
transdifferentiation
WJ-MSCs were subjected into neurogenesis as shown
before [21]. Total RNAs were collected at day 0, 3, 9 15
and 20, and real-time PCR validation of a neurogenesis-
related gene, neurofilament (NF), and a stemness mar-
ker, nestin, were performed (Figure 1A). As expected,
WJ-MSCs gradually lost their stemness while gained
neuronal features (Figure 1A, upper and middle panels).
NeuN, a neural specific marker in vertebrate [26], could
be detected in differentiated cells 3 days after induction
(Figure 1A, bottom panel).
We then analyzed the global miRNA expression pat-
terns (the “miRNome”) of WJ-MSCs and their neuronal
p r o g e n i t o r sb ym i c r o a r r a ya n a l y s i s .S i n c ew ea i mt o
identify miRNAs associated with the early events of neu-
ronal transdifferentiation, total RNAs were collected at
day 0 and day 9 post differentiations. Differentially
expressed miRNAs were identified by 2-tailed Student’s
t-test with a significance level of P < 0.05 plus ≧ 1.5-fold
change. A heat map for these miRNAs indicates their
unique expression levels between each cell group (Figure
1B). Five miRNAs were enriched in WJ-MSCs, including
hsa-miR-345, hsa-miR-106a, hsa-miR-17-5p, hsa-miR-
20a and hsa-miR-20b (Figure 1B). In contrast, 11 miR-
NAs (hsa-miR-206, hsa-miR-34a, hsa-miR-374, hsa-miR-
424, hsa-miR-100, hsa-miR-101, hsa-miR-323, hsa-miR-
368, hsa-miR-137, hsa-miR-138 and hsa-miR-377) were
abundantly expressed in day 9 neuronal progenitors
(Figures 1B and 2A).
Among miRNAs up-regulated during WJ-MSC neuro-
nal differentiation, miR-34a and miR-206 were also up-
regulated in neuronal precursors derived from BM-MSC
[21] (Figures 1B, underlined). It has been confirmed pre-
viously that miR-206 can regulate the synthesis of neu-
rotransmitter substance P in human BM-MSC-derived
neuronal cells [21]. However, roles of miR-34a in neuro-
nal precursor cells are as yet unclear. We confirmed the
up-regulation of miR-34a in day 9 neuronal progenitors
by qPCR (Figures 2B). The reduction of miR-17-5p dur-
ing neurogenesis was also confirmed (Figures 2B).
Functional module analysis as a framework for the
interpretation of miR-34a biology
To increase our knowledge on miR-34a biology and to
better explain miR-34a function, we analyzed by micro-
array the transcriptome of cells transfecting with miR-
34a oligos for finding miR-34a-regulated mRNAs. As a
result, we identified 136 miR-34a-suppressed genes were
also down-regulated in day 9 neuronal progenitors (Fig-
ure 3A; day 9 neurogenesis genes were from a published
reference [27]). These 136 genes all possessed putative
miR-34a-binding sites (Figure 3A). To understand more
how these 136 genes might be correlated with neuronal
progenitor biology and to provide quantitative evidences,
these 136 genes were subjected into the Gene Ontology
(GO) database search [28] to find statistically over-
represented functional groups within them. Given that
the whole human transcriptome was represented in
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Figure 2 Validation of miRNA array data.( A) Array hybridization signals of miR-34a and miR-17-5p. (B) Mean expression levels of miR-34a and
miR-17-5p were compared to that of U6 small nuclear RNA control. Results were done by real time RT-PCR and expressed as the mean ±
standard deviation.
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Figure 1 MiRNome analysis of umbilical cord MSCs and differentiated neural precursors.( A)( upper and middle) Histograms showing the
induction of neural differentiation in WJ-MSCs. WJ-MSCs were subjected into neurogenesis, and total RNAs were collected at the indicated time
points for real-time PCR validation. neurofilament (NF), neurogenesis-related genes; nestin, stemness gene. (lower) Immunofluorescence assays on
NeuN protein. Day 3 neuronal precursors derived from WJ-MSC were used. (B) A heat map shows the miRNA expression patterns in WJ-MSCs
(0d) and derived neural precursors which were differentiated for 9 days (9d). MiRNAs in red, increased expression; in blue, decreased.
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toward the coverage of the microarray.
The GO categories of biological processes being statis-
tically overrepresented (P < 0.05) among the 136 newly
identified miR-34a target genes are shown in Figure 3B.
Categories associated with cell motility, energy produc-
tion (including those with oxidative phosphorylation,
electron transport and ATP synthesis), and actin cytos-
keleton organization were all significantly (P < 0.05)
repressed by miR-34a (Figure 3B, underlined). Details of
miR-34a-targeted genes involved in cell motility or oxi-
dative phosphorylation are listed in Figure 3C.
Suppression of MSC motility by miR-34a
MiR-34a has been linked to reduced cell motility in can-
cer cells [15]. The suppression of cytoskeleton-related
genes and cell motility genes indicates that miR-34a
may also regulate MSC motility. The suppression of
ATP-synthesis genes by miR-34a further indicates this
possibility. We examined our hypothesis by manipulat-
ing miR-34a levels in MSCs. We knocked down endo-
genous miR-34a expression in MSCs and performed cell
motility assays. As shown in Figure 4, WJ-MSC motility
was increased (Figure 4B) when the endogenous miR-
34a level was reduced (Figure 4A). On the contrary, cel-
lular motility was reduced when miR-34a was overex-
pressed in cells (Figures 4C-D). Of note, cell viability
was not significantly affected by knocking down or over-
expressing miR-34a in MSCs (not shown).
Discussion
MSCs isolated from various anatomic locations exhibit
immune-suppressive properties, follow a pattern of mul-
tilineage differentiation, including neuronal transdiffer-
entiation [29,30]. MSCs thereby provide an alternate
source of neuronal cells for tissue repair, with potential
Figure 3 Gene expression microarray analysis for finding miR-34a-regulated genes and biological modules.( A) A Venn diagram shows
that 136 miR-34a-affected genes are decreased in 9d precursors [27]. These genes all contain putative miR-34a binding sites revealed by the
miRTar webtool http://mirtar.mbc.nctu.edu.tw/human/. (B) The above 136 genes were subjected to the GO database search via the DAVID
Bioinformatics Resources 6.7 database http://david.abcc.ncifcrf.gov/. These categories were selected from the Biological Process organizing
principle in the GO project http://www.geneontology.org/. The number of genes and P values for each category are also listed. Underlined:
discussed in the text. (C) Motility and oxidative phosphorylation genes (mapped by the WebGestalt http://bioinfo.vanderbilt.edu/webgestalt/
interface) which are targeted by miR-34a. Numbers of targets sites within the 3’ UTR of each gene are shown.
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are small RNAs of 18-24 nucleotides in length that are
involved in the regulation of gene expression and hence
a variety of biological processes, including stem cell dif-
ferentiation, through post-transcriptional RNA interfer-
ence-based mechanisms [11-13,21]. How miRNAs are
involved in MSC neurogenesis or in the activities of dif-
ferentiated neuronal precursors remain largely unclear.
It has been reported that in BM-MSC-derived neurons
(day 12), 32 miRNAs are altered, including miR-206 and
miR-34a [21]. In this differentiation system, MSC-derived
neurons express the neurotransmitter gene, Tac1, at the
level of transcription, but without translation to its
encoded neurotransmitter substance P (SP) [21]. How-
ever, stimulation with the proinflammatory mediator, IL-
1a, resulted in Tac1 mRNA translation. IL-1a thereby
alleviates translational repression of Tac1 mRNA through
negative effects on miRNAs. MiR-206 is one of the miR-
NAs down-regulated by IL-1a, while miR-34a is still
abundant in day 12 neurons in the presence or absence
of IL-1a [21]. This data indicates that miR-34a is
involved in functions other than SP production. In this
work we show that miR-34a modulates genes involved in
cellular motility and oxidative phosphorylation in WJ-
MSC-derived neural precursors. These clues came from
microarray analysis on cells overexpressing miR-34a (Fig-
u r e3 ) .O fn o t e ,m i c r o a r r a ye x p e r i m e n tw i l lo n l yi d e n t i f y
genes that are regulated at the mRNA stability levels by
miR-34a and not the genes that are regulated through
changes in translation. The direct inhibition of miR-34a
downstream targets by miR-34a, however, is still to be
test by more direct assays such as 3’-UTR reporter assays
and immunoblotting. We proved that miR-34a contri-
butes in cell motility in WJ-MSCs. Whether miR-34a
also regulates BM-MSC motility and ATP production is
under investigation.
Cell motility plays a crucial role in stem cell-based
therapy. In a middle cerebral artery occlusion (MCAO)
rat model, engrafted WJ-MSCs could migrate to the
penumbric area to repair the ischemic boundary zone
and differentiated into glial, neuronal, doublecortin+,
CXCR4+, and vascular endothelial cells to enhance neu-
roplasticity in the ischemic brain [2]. Knocking down
endogenous miR-34a in transplanted MSCs may
enhance cell motility and energy production, thereby
favoring engrafted WJ-MSCs or their neuronal progeni-
tors to locate to injured locations in vivo.
The expression of miR-34a is regulated by p53, and
introducing miR-34a into cancer cells results in apopto-
sis, senescence and/or cell-cycle arrest [31]. In prostate
cancer, miR-34a inhibits cancer stem cells and metasta-
sis by directly repressing CD44 [32]. miR-34a is also
tumor suppressive in brain tumors and glioma stem
cells and can induce cancer cell differentiation [16].
However, miR-34a is overexpressed in various types of
human cancers and can support cell proliferation in
renal carcinogenesis [14]. The roles of miR-34a in differ-
ent cell types are therefore different, which may due to
the differential expression of miR-34a target mRNAs in
a different context. In mouse embryonic stem cells
(ESCs), the suppression of miR-34a by anti-miR caused
the block of ESC differentiation induced by LIF withdra-
wal [33]. For the bipotent K562 human leukemia cells,
miR-34a is strongly up-regulated during phorbol ester-
induced megakaryocyte differentiation [34]. Whether
niR-34a is also involved in BM-MSC and WJ-MSC dif-
ferentiation is another interesting direction to follow.
In summary we have identified miRNome changes
during WJ-MSC transdifferentiation into neurons and
have found novel miR-34a downstream targets. The
Figure 4 MiR-34a regulates cell motility.( A-B)W J - M S C sw e r e
transfected with siRNA against miR-34a, or with a scramble siRNA
negative control. MiR-34a expression levels were detected by real
time RT-PCR (A), and the relative cell migration ability was
measured at 48 h posttransfection (B). Data shown represent an
average of 10 wells. Asterisks, P < 0.05. (C-D) WJ-MSCs were
transfected with miR-34a or with scramble oligonucleotides. MiR-34a
levels were detected by real time PCR (C) and the relative cell
migration ability was measured at 48 h posttransfection (D).
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by miR-34a, however, is still to be test by more direct
assays such as 3’-UTR reporter assays and immunoblot-
ting. Roles of other filtrated miRNAs in MSC neuronal
differentiation are also waited to be checked in the
future. We also found that 4 miRNAs belonging to the
miR-17 family (that is, miR-20a, miR-20b, miR-17-5p
and miR-106a) are down-regulated during WJ-MSC
neurogenesis (Figures 1, 2). How these miRNAs work
together in maintaining stemness will be a critical issue
to address.
Conclusions
We have identified miRNome changes during WJ-MSC
transdifferentiation into neurons and have identified the
miRNome pattern during then e u r o g e n e s i so fW J - M S C .
MiR-34a and miR-206 were the only 2 miRNAs which
were commonly down-regulated during neuronal differ-
entiation in both WJ-MSC and BM-MSC. MiR-34a sup-
pressed the expression of 136 neuronal progenitor genes,
and gene enrichment analysis showed that these genes
were associated with cell motility and energy production.
In silico data were verified by wetlab experiments, which
proved that miR-34a can inhibit WJ-MSC motility. Our
data suggest a critical role of miRNAs in MSC activities
and neuronal differentiation, and miR-34a contributes in
neuronal precursor motility, which may be crucial for
stem cells to home to the target sites they should be.
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